Strides Pharma Expands Africa Biz
Strides Pharma to acquire generic brands from Sandoz. Initial investment of $12 million.
Nadia Okonkwo
Tech & Business Reporter
Introduction to Expansion
Strides Pharma Science is set to strengthen its presence in Sub-Saharan Africa. This move is part of a strategic plan to enhance its position in the region.
Acquisition Details
The company is acquiring branded generic products from Sandoz AG with an initial investment of USD 12 million. This acquisition is expected to catapult Strides into the ranks of the top five pharmaceutical firms in the region.
RELATED READING
SOURCES & REFERENCES
This article was researched and compiled by the PulseAfrica editorial team using information from international news sources including Reuters, BBC Africa, Al Jazeera, AFP, and local African media outlets. PulseAfrica is committed to accurate, balanced and independent journalism covering all 54 African nations in three languages.
